
Sign up to save your podcasts
Or


In this episode of The Upgrade podcast, we discuss Sotera and Parexel; how they have fared in the pandemic and what would be required for an upgrade. We also discuss where they rank in the Top 250 and how their respective debt pricing may be viewed by CLO managers. Guests are analysts from S&P's U.S. corporate ratings healthcare team and CLO team.
By S&P Global Ratings4.8
44 ratings
In this episode of The Upgrade podcast, we discuss Sotera and Parexel; how they have fared in the pandemic and what would be required for an upgrade. We also discuss where they rank in the Top 250 and how their respective debt pricing may be viewed by CLO managers. Guests are analysts from S&P's U.S. corporate ratings healthcare team and CLO team.

6 Listeners

40 Listeners

9 Listeners

6 Listeners

676 Listeners

28 Listeners

29 Listeners

10 Listeners

4 Listeners

64 Listeners

30 Listeners

11 Listeners

28 Listeners

1 Listeners

3,082 Listeners

5 Listeners

3 Listeners

0 Listeners

6 Listeners

5 Listeners

5 Listeners